Washington, United States,
08048034981
Bleocel 15 IU Injection Exporter from India to USA, NZ & Zimbabwe | City Drug House
City Drug House India exports Bleocel 15 IU Injection to the USA, New Zealand and Zimbabwe. Contact us for pharmaceutical supply and export inquiries.

Bleocel 15IU Injection contains bleomycin, an antineoplastic antibiotic used to treat squamous cell cancers, certain lymphomas, and to prevent fluid buildup in the lungs.

Frequently Asked Questions

What does Bleocel 15IU Injection treat?
Squamous cell cancers: Treats cancers of the head, neck, cervix, skin, and external genitalia.
Blood cancers: Used for Hodgkin's and non-Hodgkin's lymphoma.
Fluid accumulation: Helps prevent and treat fluid build-up in the lungs caused by tumors.

Does it cause pulmonary fibrosis, nausea, or hair loss?
Yes: It can cause nausea, hair loss, and pulmonary fibrosis (scarring of lung tissue).
Lung impact: Pulmonary fibrosis happens because the lungs lack enough of the specific enzyme needed to break down the medicine.

How does Bleocel 15IU work?
Cell damage: It stops cancer cells from growing by breaking their DNA and RNA strands so they cannot divide.

Administration: A trained healthcare provider injects it into a vein, a muscle, or under the skin.

What are the safety warnings?
Pregnancy and breastfeeding: It is unsafe during breastfeeding and not recommended during pregnancy due to high risk to the baby.
Monitoring: Doctors require regular blood tests and breathing checks to watch your lungs, kidneys, and blood counts.

/bleocel-15-iu-injection-exporter-india-usa-new-zealand-zimbabwe

City Drug House Exporters provides:

Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :

📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 7666132978
Aug 25th, 2026 1:48 PM

Keywords